Osteoarthritis of the Hip
Conditions
Brief summary
This study evaluates post-operative pain management and narcotic consumption in patients receiving a fascia iliaca block with local anesthetic versus patients receiving fascia iliaca block with saline for total hip arthroplasty.
Detailed description
Although many improvements have been made in implant technology and surgical approaches for total hip arthroplasty, management of post-operative pain remains a major clinical issue. Inadequate pain control can lead to numerous unwanted side effects and limited physical function, especially in a older population. Most surgeons have adopted a multi-modality pain management approach using a variety of pharmaceuticals, including nerve block with local anesthetic. In the literature, there are a number of technical variations described for the fascia iliaca nerve block. At The Christ Hospital, Cincinnati, Ohio, anesthesiologists use a more proximal approach to the fasica iliaca block enabling a significantly easier cephalad spread of the local anesthetic into the pelvis targeting all three nerves; the femoral, lateral femoral cutaneous, and the obturator. This prospective, double-blinded, randomized, single-center study is designed to test the primary hypothesis that fascia iliaca block with a local anesthestic decreases narcotic consumption and provides improved pain control compared to placebo in the first 24 hours after surgery in patients undergoing total hip arthroplasty.
Interventions
0.375% ropivacaine as a one-time, 60 milliliter injection
Saline as a one-time, 60 milliliter injection.
Sponsors
Study design
Eligibility
Inclusion criteria
* anterior approach total hip arthroplasty (THA) for unilateral osteoarthritis * English-speaking * age 18 to 75 years * American Society of Anesthesiologists (ASA) physical status 1 to 3 * BMI \< 40 kg/m2 * Minimum weight of 50 kg. * No contraindications to study procedures
Exclusion criteria
* Hip revision surgery * Allergy to local anesthetics * Allergy to oxycontin * Allergy to pregabalin * Allergy to fentanyl * Allergy to midazolam * Allergy to hydromorphone * BMI \> 40 kg/m2 * Chronic pre-operative opioid use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Control | 24 hours | Measured by NRS-11 beginning in post-operative care unit and continuing 24 hours on the post-operative floor. |
| Opioid Consumption | 24 hours | Measured by IV narcotic consumption beginning in the post-operative care unit and continuing 24 hours on the post-operative floor. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Post-Operative Care Unit (PACU) Length of Stay | From 60 minutes to 6 hours | Length of PACU stay is measured from arrival in PACU to clinical discharge from PACU |
Countries
United States